Cargando…
Reimbursement categories as a way of allocating measures and monitoring expenditures on medicines
Autores principales: | Lipińska, Aneta, Pomorski, Maciej, Matusewicz, Wojciech, Jagodzińska-Kalinowska, Katarzyna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4603336/ http://dx.doi.org/10.1186/2052-3211-8-S1-P24 |
Ejemplares similares
-
Determining the prices of the medicines in the absence of superiority over alternative medical technology
por: Matusewicz, Wojciech, et al.
Publicado: (2015) -
Impact of delisting OTC medicines from reimbursement list
por: Chytilová, Petra, et al.
Publicado: (2015) -
Retrospective financial analysis of medicines reimbursement services in community pharmacy
por: Chitan, Elena
Publicado: (2015) -
Reimbursement policy optimization for Angiotensin-converting enzyme (ACE) inhibitors in Bulgaria: Controlling expenditure without undermining access to treatment
por: Kazakov, Rossen M, et al.
Publicado: (2015) -
Diagnosis-related group-based reimbursement is unrealistic for ICUs
por: Mclaughlin, A, et al.
Publicado: (2009)